Interleukin(IL)-4 and IL-4 receptors in regulation of type 2 immune responses

Description of the granted funding

Immune response protects us against invading pathogens; viruses, bacteria, parasites and yeasts. Inappropriately activated immune response can result in autoimmune reaction or allergic reaction. Humoral mediators, cytokines, are critical regulators of various immune responses. This study clarifies, how cytokines especially Interleukin(IL)-4 regulates allergic inflammation. By understanding how IL-4 and its cell surface receptors function, its' therapeutical utilization, for example in autoimmune diseases to redirect immune response to less inflammatory direction may become possible. In this study, we utilize genetically modified knockout and transgenic mice (some of which are unpublished), clinical samples and cell culture models. The study is collaborative project between, TaY, TAYS, Fimlab Inc and NIH (USA) and is based on my previous research (Junttila I et al., J. Exp Med., 2008, Junttila I et al. Nat Chem Biol., 2012, Junttila I et al. J Allergy Clin Immunol., 2013).
Show more

Starting year

2017

End year

2022

Granted funding

Ilkka Junttila Orcid -palvelun logo
100 788 €

Related funding decisions

314204
Research costs of Academy Research Fellows(2017)
64 800 €
335742
Research costs of Academy Research Fellows(2020)
200 845 €
326380
Research costs of Academy Research Fellows(2019)
260 287 €
326379
Academy research fellows(2019)
333 696 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

308048

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

biotechnology, biomedicine